<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Bio Expo Online</title>
<link>http://www.bioexpoonline.com/index/</link>
<description>Bio Expo Online</description>
<generator>BBDMS 1.0.0</generator>
<managingEditor>info@bioscreening.com (Somebody)</managingEditor>
<webMaster>info@bioscreening.com (Somebody)</webMaster>
<pubDate>Mon, 12 May 2008 03:37:36 -0400</pubDate>
<lastBuildDate>Mon, 12 May 2008 03:37:36 -0400</lastBuildDate>
<language>en</language>
<copyright>Copyright by Somebody</copyright>
<item>
<title>BIO-Europe Spring Launches in Milan</title>
<link>http://www.bioeuropespring.com</link>
<description>
<![CDATA[ BIO-Europe Spring(TM) Launches in Milan: Business Leaders, International Biotech Industry and Italian Government Welcome New Springtime Biotech Partnering Conference

<p>

Milan, Italy, January 16, 2007: At a press conference held today at the Palazzo Marino (Sala Alessi), leaders from the Italian government, the city of Milan (with the Mayor, Miss Letizia Moratti) and luminaries from both the Italian and global biotechnology industry officially inaugurated BIO-Europe Spring. Held at the Milano Convention Center (MIC), March 5-7, 2007, BIO-Europe Spring will be the preeminent springtime partnering conference for the biotechnology industry as well as a valued counterpart to BIO-Europe, the world’s largest standalone biotechnology partnering conference. 


<p>

“We are excited that the EBD Group has chosen Milan as the venue to unveil its latest biotech partnering conference, BIO-Europe Spring. When leaders of the global biotech industry gather here in March they will discover a city and region poised to become a leading center for scientific knowledge and discovery, adding to Milan’s well-known reputation as the center of the design and fashion world,” said Alessandro Sidoli, Chief Operating Officer of Axxam and Vice President of Assobiotec, the Italian Bioindustry Association, that organizes the event in partnership with EBD.


<p>

Strategic partnering is becoming an increasingly important element for companies operating in the biotechnology industry. In this highly competitive and rapidly globalizing industry, successful partnering strategies help companies gain access to new markets, funding, and identify new intellectual property for in-licensing. BIO-Europe Spring and its sister conference, BIO-Europe, use EBD Group's proprietary state-of-the-art web-based partnering software platform that enables firms from every part of the biotechnology value-chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. 


<p>

“We are proud to inaugurate our new partnering event in Milan, a city that throughout history has seen the technological innovations giving shape and meaning to the modern world,” said Carola Schropp, Founder of the leading partnering firm in the biotechnology industry, the EBD Group. “Designed as the counterpart to our flagship conference BIO-Europe, the BIO-Europe Spring event will feature the powerful combination of one-on-one partnering meetings and company presentations characteristic of all of EBD’s partnering events. It will bring together international decision-makers from all biotechnology sectors, pharmaceutical companies and financial firms.”


<p>

About EBD Group

<p>
EBD Group is the leading partnering firm for the global biotechnology industry. For over 12 years, firms in the life sciences have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business. EBD Group’s conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, the world’s largest stand-alone life science partnering conference; BIO-Europe Spring; the investor conference BioEquity Europe conference (co-organized with BioCentury Publications); and the medical technology partnering conference, BioDevice Partnering. EBD’s proprietary software system also powers partnering at numerous third-party events around the world. Outside of the conference format, EBD Group’s consultants can provide hands-on operational consulting for firms seeking to in- or out license products and technologies.

<p>


EBD Group has offices in San Diego, Munich and London. For more information visit www.ebdgroup.com or www.bioeuropespring.com for conference related issues. ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Wed, 07 Feb 2007 15:00:00 -0500</pubDate>
</item>
<item>
<title>ORGANIC CHEMISTRY, PRESENT AND FUTURE</title>
<link>http://www.ghosezsymposium.org</link>
<description>
<![CDATA[ A four-day International Symposium organised in honour of Prof. Léon Ghosez 

<p>
April 10 - 13, 2007 Louvain-la-Neuve (Belgium)

<p>
There are already 300 participants! 

<p>
You can still REGISTER for the symposium and if you would like to submit an abstract please send it to us at: ghosezsymposium@LDOrganisation.com

<p>
All information is available under www.ghosezsymposium.org. 

<p>
SYMPOSIUM PROGRAMME

<p>
The Symposium will start on Monday April 9, 2007 for registration. The scientific program will begin on Tuesday April 10, 2007 and finish on Friday April 13, 2007. Along with the 24 invited lectures, the four-day international symposium programme will provide, during lunch time, a forum for presentation and discussion through poster sessions, which will be organised together with a commercial exhibition.

<p>
CONFIRMED SPEAKERS

<p>


Catalytic and Asymmetric Vinylogous Mukaiyama Reactions: Methodology and Synthetic Applications Dr. Jean-Marc CAMPAGNE, (ENSCM, Montpellier, France) 


<p>
Novel Ligands and Reactions in Asymmetric Catalysis 
Dr. Juan Carlos CARRETERO, (UNIVERSIDAD AUTONOMA de MADRID, Madrid, Spain) 


<p>
Selective Reactions and their Use in the Synthesis of Biologically Active Natural Products 
Prof. Janine COSSY, (ESPCI, Paris, France) 
<p>

Fluorous Mixture Synthesis Approaches to Natural Product Stereoisomer Libraries 
Prof. Dennis P. CURRAN, (UNIVERSITY of PITTSBURGH, Pittsburgh, United States) 
<p>
Organic Nanochemistry 
Prof. François DIEDERICH, (ETH-ZURICH, Zürich, Switzerland) 

<p>
Studies in Natural Products Synthesis 
Prof. David A. EVANS, (HARVARD UNIVERSITY, CAMBRIDGE, United States) 
<p>

New Chemistry from an Old-timer!
Prof. Léon GHOSEZ, (UCL, Louvain-la-Neuve, Belgium) 

<p>
Radical Chemistry with Amino Acids and Peptides 
Prof. Bernd GIESE, (UNIVERSITAT BASEL, Basel, Switzerland) 

<p>
Discovery, Understanding and Applications of New Fluorination Processes 
Dr. Véronique GOUVERNEUR, (UNIVERSITY of OXFORD, Oxford, United Kingdom) 

<p>
Novel Modified Nucleobases, Nucleosides and Nucleotides: Synthesis, Biological Activity and Applications 
Dr. Michal HOCEK, (IOCB, ACADEMY of SCIENCES, Prague, Czech Republic) 

<p>
Protein-sized Synthetic Folded Architectures 
Dr. Ivan HUC, (IECB, Pessac, France) 
<p>

>From Supramolecular Chemistry to Constitutional Dynamic Chemistry 
Prof. Jean-Marie LEHN, (ISIS/ULP, Strasbourg, France) 

<p>
Natural Product Synthesis: a Stimulus for Discovery 
Prof. Steven V. LEY, (UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom) 

<p>
Reactivity and Conformational Flexibility: a Study of Bridged Azetidinones 
Prof. Jacqueline MARCHAND-BRYNAERT, (UCL, Louvain-la-Neuve, Belgium) 
<p>

New Methods for the Preparation of Enantiomerically Pure Quaternary Carbon Centers 
Prof. Ilan MAREK, (TECHNION-ISRAEL INSTITUTE of TECHNOLOGY, Haifa, Israel) 

<p>
Efficient and Connective Synthesis of Natural Products 
Prof. Istvan MARKO, (UCL, Louvain-la-Neuve, Belgium) 

<p>
Total Synthesis of Bioactive Natural Products: Complex Targets-Simple Solutions 
Prof. Goverdhan MEHTA, (INDIAN INSTITUTE of SCIENCE, Bangalore, India) 
<p>

Fine Approach to Polymer Synthesis 
Prof. Kyoko NOZAKI, (The University of Tokyo, Tokyo, Japan) 
<p>
Dearomatization of Phenols – Why, How and What for? 
Prof. Stéphane QUIDEAU, (UNIVERSITE de BORDEAUX 1, Talence, France) 
<p>

Chiral Metal Hydrides for Asymmetric Catalysis 
Prof. Olivier RIANT, (UCL, Louvain-la-Neuve, Belgium) 

<p>
Rapid Formation of Molecular Complexity in Natural Product Synthesis 
Prof. Erik SORENSEN, (PRINCETON UNIVERSITY, Princeton, United States) 
<p>

Adventures in Peptide Synthesis and Molecular Recognition 
Dr. Laurent TREMBLEAU, (UNIVERSITY of ABERDEEN, Aberdeen, United Kingdom) 
<p>

Post-Translational Glycosylation: Problems and Opportunities 
Prof. Chi-Huey WONG, (The SCRIPPS RESEARCH INSTITUTE, La Jolla, United States) 
<p>

Catalytic Asymmetric Synthesis 
Dr. Hisashi YAMAMOTO, (UNIVERSITY of CHICAGO, Chicago, United States) 
<p>
A Quest for New Reactions: Some Interesting Perspectives for Organic Synthesis 
Prof. Samir ZARD, (ECOLE POLYTECHNIQUE, Palaiseau, France) 

<p>

Symposium Secretariat

LD ORGANISATION

+32 10 45 47 77
+32 10 45 97 19
E-mail : secretariat@LDOrganisation.com
Url : http://www.LDOrganisation.com ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Wed, 07 Feb 2007 14:56:00 -0500</pubDate>
</item>
<item>
<title>SBS 13th Annual Conference & Exhibition</title>
<link>http://www.sbsonline.org</link>
<description>
<![CDATA[ Society for Biomolecular Sciences

Presents its 13th Annual Conference & Exhibition

Advancing the Science of Drug Discovery: Bridging Research & Development

April 15-19, 2007

Palais Des Congres de Montréal

Montréal, Canada

After the Society's most successful annual event in Seattle this year, professionals from around the globe will want to participate in the next SBS Annual Conference & Exhibition in April 2007. This will be the first spring annual the Society has scheduled.

The SBS event, the premier scientific and showcase event in molecular discovery, brings together more than 2,900 professionals, offering a unique opportunity to learn more about the latest innovations, technologies, and research in the drug discovery sciences from all over the world. Session topics include:

· Advances in Screening Technologies
· Biomarkers: From Bench to Clinic
· Compound Management: Challenges & Automation Solutions
· Enzyme Targets: Black Box or Whole Cell Assays?
· From Gene to Target: Functional Target Validation Strategies
· High-Content Cellular Screening
· Immunotherapeutics, mAbs & Translational Medicine
· Structural Biology: Underpinning Drug Discovery
· Systems Biology & High-Throughput Approaches to Screening Native Cells
· Target Biology & Screening: GPCRs
· Target Biology & Screening: Ion Channels
· Toxicity Profiling Using High-Throughput & High-Content Technologies



Contact:

Marietta Manoni, CMP

Conference Manager

mmanoni@sbsonline.org

Society for Biomolecular Sciences

36 Tamarack Avenue, #348, Danbury, CT 06811, USA

Phone: +1 (203) 743-1336

Fax: +1 (203) 748-7557

www.sbsonline.org ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Thu, 25 Jan 2007 19:50:00 -0500</pubDate>
</item>
<item>
<title>NEXUS Biosystems' Universal Store Compound Management System Selected as Key Component of Vanderbilt University's High-Throughput Screening Facility</title>
<link>http://www.bioscreening.net/2007/01/12/nexus-biosystems-universal-store-compound-management-system-selected-as-key-component-of-vanderbilt-universitys-high-throughput-screening-facility/</link>
<description>
<![CDATA[ NEXUS Biosystems announced that Vanderbilt University’s High-Throughput Screening (HTS) Facility has selected the Universal Store to manage its ever-growing collection of synthetic small molecules and natural products. The Universal Store will serve as the main repository for maintaining and managing Vanderbilt’s collection as a part of its basic research and translational drug discovery activities. […] ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Fri, 12 Jan 2007 22:06:00 -0500</pubDate>
</item>
<item>
<title>Virtual screening services collaboration between Quantum Pharma and TimTec</title>
<link>http://www.bioscreening.net/2006/09/06/virtual-screening-services-collaboration-between-quantum-pharma-and-timtec/</link>
<description>
<![CDATA[ Quantum Pharma, a drug discovery and computational chemistry software and contract services provider, Moscow, Russia, and TimTec, a provider of synthetic organic and natural compounds for bioscreening, Delaware, US, singed up a collaboration agreement. Quantum computational chemistry software with unique capabilities is available now through TimTec. In the future companies will co-develop products for drug-discovery […] ]]>
</description>
<author>info@bioscreening.com (Somebody)</author>
<pubDate>Wed, 06 Sep 2006 19:59:00 -0400</pubDate>
</item>
</channel>
</rss>
